Seeing Is Believing
Currently out of the existing stock ratings of Joseph Thome, 32 are a BUY (68.09%), 15 are a HOLD (31.91%).
Analyst Joseph Thome, currently employed at TD COWEN, carries an average stock price target met ratio of 49% that have a potential upside of 26.43% achieved within 130 days. Previously, Joseph Thome worked at COWEN.
Joseph Thome’s has documented 95 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PTCT, PTC Therapeutics at 05-Nov-2025.
Analyst best performing recommendations are on PTCT (PTC THERAPEUTICS).
The best stock recommendation documented was for PTCT (PTC THERAPEUTICS) at 7/20/2020. The price target of $50 was fulfilled within 1 day with a profit of $3.29 (6.17%) receiving and performance score of 61.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Apr-2025
$245
$61.28 (33.36%)
$200
23 days ago
(03-Feb-2026)
0/2 (0%)
$57.65 (30.77%)
Buy Since 08-Apr-2019
$205
$21.28 (11.58%)
$85
29 days ago
(28-Jan-2026)
7/8 (87.5%)
$19.83 (10.71%)
433
Buy Since 07-Jun-2018
$260
$76.28 (41.52%)
$200
1 months 6 days ago
(20-Jan-2026)
21/43 (48.84%)
$75.5 (40.92%)
527
Buy Since 08-Aug-2023
$223
$39.28 (21.38%)
$113
1 months 10 days ago
(16-Jan-2026)
3/4 (75%)
$45.73 (25.80%)
189
Buy Since 03-Sep-2025
$193
$9.28 (5.05%)
$157
1 months 13 days ago
(13-Jan-2026)
2/3 (66.67%)
$18.67 (10.71%)
88
Which stock is Joseph Thome is most bullish on?
Which stock is Joseph Thome is most reserved on?
What Year was the first public recommendation made by Joseph Thome?